SK Biopharmaceuticals Co., Ltd. (KRX: 326030)
South Korea
· Delayed Price · Currency is KRW 106,200
+3,000 (2.91%)
Feb 4, 2025, 9:00 AM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 8.32 trillion as of February 4, 2025. Its market cap has increased by 10.40% in one year.
Market Cap
8.32T
Enterprise Value
8.25T
Revenue
511.33B
Ranking
n/a
PE Ratio
144.94
Stock Price
106,200.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 8.32T, a decrease of -16.38%. That is a compound annual growth rate of -3.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2025 | 8,316.87B | -4.41% |
| Dec 30, 2024 | 8,700.60B | 10.66% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.94T |
| Celltrion | 37.33T |
| Yuhan | 9,232.03B |
| SK bioscience | 3,705.83B |
| Hanmi Pharm. | 2,967.17B |
| Hanall Biopharma | 1,952.35B |
| Hanmi Science | 1,811.34B |
| Daewoong Pharmaceutical | 1,516.53B |